Document Detail


Liquid ventilation: clinical experiences.
MedLine Citation:
PMID:  10360215     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Liquid breathing has been in the medical literature for nearly 80 years and has been proposed as a means of improving gas exchange in patients with acute respiratory failure since the 1970s. There are many potential clinical applications of perfluorochemical (PFC) liquids that span many specialties in medicine. The ability to lower surface tension directed the initial clinical focus on neonatal therapy in the treatment of respiratory distress syndrome. The first clinical trial of PFC ventilation was performed in neonates in 1989. Additional trials using LiquiVent, a medical-grade PFC liquid, were initiated in 1993 in infants, children, and adults with severe respiratory distress. Based on the results of several studies during this time, it was concluded that the technique of liquid ventilation seemed to be safe, improve lung function, and recruit lung volume in patients from these various populations. More than 100 patients from preterm neonates to elderly patients with respiratory distress have been studied. In general, patients experience improvement in lung function and oxygenation, without adverse events. The results of such trials are encouraging and suggest the feasibility of this technique in the neonate with severe respiratory failure requiring respiratory support. Limitations of the technique include a limited understanding of how it works and its effectiveness in different patient populations. It has also become evident that there is a need for additional diagnostic and therapeutic instrumentation to expedite its implementation in the intensive care environment. This article discusses clinical experiences with liquid ventilation and highlights the technical needs to facilitate its implementation in respiratory care management.
Authors:
J S Greenspan; M R Wolfson; T H Shaffer
Related Documents :
8031425 - Life-threatening hypotension associated with emergency intubation and the initiation of...
8289075 - Widespread multiple system degeneration in a patient with familial amyotrophic lateral ...
16909375 - Acute lung injury and acute respiratory distress syndrome: extracorporeal life support ...
10882265 - Transjugular intrahepatic portosystemic shunts (tips): effects of respiratory state and...
23146615 - Assessment of swallowing in motor neuron disease and asidan/sca36 patients with new met...
12872855 - Effects of vitamin supplementation on microcirculatory disturbance in hemodialysis pati...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Biomedical instrumentation & technology / Association for the Advancement of Medical Instrumentation     Volume:  33     ISSN:  0899-8205     ISO Abbreviation:  Biomed Instrum Technol     Publication Date:    1999 May-Jun
Date Detail:
Created Date:  1999-08-02     Completed Date:  1999-08-02     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8905560     Medline TA:  Biomed Instrum Technol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  253-9     Citation Subset:  IM    
Affiliation:
Department of Neonatology, Jefferson Medical College, Philadelphia 19107, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Child
Child, Preschool
Clinical Trials as Topic
Fluorocarbons / administration & dosage*,  chemistry
Humans
Infant
Infant, Newborn
Infant, Premature
Life Support Care / methods
Middle Aged
Pulmonary Gas Exchange
Respiration, Artificial / methods*
Chemical
Reg. No./Substance:
0/Fluorocarbons

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Implantable defibrillator recipients' responses to device implantation and design.
Next Document:  Multifactorial analysis of exchanger efficiency and liquid conservation during perfluorochemical liq...